Novel familial distal imprinting centre 1 (11p15.5) deletion provides further insights in imprinting regulation.


Journal

Clinical epigenetics
ISSN: 1868-7083
Titre abrégé: Clin Epigenetics
Pays: Germany
ID NLM: 101516977

Informations de publication

Date de publication:
15 02 2019
Historique:
received: 08 10 2018
accepted: 08 02 2019
entrez: 17 2 2019
pubmed: 17 2 2019
medline: 21 8 2019
Statut: epublish

Résumé

Deletions of the imprinting centre 1 (IC1) in 11p15.5 are rare and their clinical significance is not only influenced by their parental origin but also by their exact genomic localization. In case the maternal IC1 allele is affected, the deletion is associated with the overgrowth disorder Beckwith-Wiedemann syndrome (BWS) and a gain of methylation (GOM) of the IC1. The consequences of deletions of the paternal IC1 allele depend on the localization and probably the binding sites of methylation-specific DNA-binding factors affected by the change. It has been suggested that distal deletions of the paternal allele are associated with a normal IC1 methylation and phenotype, whereas proximal alterations cause a loss of methylation (LOM) and Silver-Russell syndrome (SRS) features. In a patient referred for molecular BWS testing and his family, a deletion within the IC1 was identified by MLPA. It was associated with a GOM, corresponding to the transmission of the alteration via the maternal germline. Accordingly, the deletion was also detectable in the maternal grandmother, but here the paternal chromosome 11p15.5 was affected and a IC1 LOM was observed. By nanopore sequencing, the localization of the deletion could be precisely determined. We report for the first time both GOM and LOM of the IC1 in the same family, caused by transmission of a 2.2-kb deletion in 11p15.5. Nanopore sequencing allowed the precise characterization of the change by long-read sequencing and thereby provides further insights in the regulation of imprinting in the IC1.

Sections du résumé

BACKGROUND
Deletions of the imprinting centre 1 (IC1) in 11p15.5 are rare and their clinical significance is not only influenced by their parental origin but also by their exact genomic localization. In case the maternal IC1 allele is affected, the deletion is associated with the overgrowth disorder Beckwith-Wiedemann syndrome (BWS) and a gain of methylation (GOM) of the IC1. The consequences of deletions of the paternal IC1 allele depend on the localization and probably the binding sites of methylation-specific DNA-binding factors affected by the change. It has been suggested that distal deletions of the paternal allele are associated with a normal IC1 methylation and phenotype, whereas proximal alterations cause a loss of methylation (LOM) and Silver-Russell syndrome (SRS) features.
RESULTS
In a patient referred for molecular BWS testing and his family, a deletion within the IC1 was identified by MLPA. It was associated with a GOM, corresponding to the transmission of the alteration via the maternal germline. Accordingly, the deletion was also detectable in the maternal grandmother, but here the paternal chromosome 11p15.5 was affected and a IC1 LOM was observed. By nanopore sequencing, the localization of the deletion could be precisely determined.
CONCLUSIONS
We report for the first time both GOM and LOM of the IC1 in the same family, caused by transmission of a 2.2-kb deletion in 11p15.5. Nanopore sequencing allowed the precise characterization of the change by long-read sequencing and thereby provides further insights in the regulation of imprinting in the IC1.

Identifiants

pubmed: 30770769
doi: 10.1186/s13148-019-0629-x
pii: 10.1186/s13148-019-0629-x
pmc: PMC6377752
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

30

Références

Nat Rev Endocrinol. 2017 Feb;13(2):105-124
pubmed: 27585961
Pediatr Dev Pathol. 2010 Jul-Aug;13(4):326-30
pubmed: 20028213
Am J Med Genet A. 2017 Jan;173(1):72-78
pubmed: 27612309
Nat Genet. 2008 Aug;40(8):949-51
pubmed: 18622393
Eur J Med Genet. 2009 Nov-Dec;52(6):415-6
pubmed: 19632365
PLoS One. 2013 Dec 06;8(12):e81962
pubmed: 24324735
Eur J Hum Genet. 2012 Jan;20(1):119-21
pubmed: 21863059
Clin Epigenetics. 2016 May 04;8:47
pubmed: 27152123
Proc Natl Acad Sci U S A. 2016 Sep 27;113(39):10938-43
pubmed: 27621468
Nat Rev Endocrinol. 2018 Apr;14(4):229-249
pubmed: 29377879
Clin Genet. 2012 Apr;81(4):350-61
pubmed: 22150955
Clin Epigenetics. 2018 Feb 21;10:23
pubmed: 29484033
Hum Mutat. 2017 Jan;38(1):105-111
pubmed: 27701793
Hum Mol Genet. 2013 Feb 1;22(3):544-57
pubmed: 23118352
Genome Res. 2006 Jul;16(7):901-11
pubmed: 16760423

Auteurs

Florian Kraft (F)

Institute of Human Genetics, Medical Faculty, RWTH Aachen University, Pauwelsstr. 30, D-52074, Aachen, Germany.

Katharina Wesseler (K)

Institute of Human Genetics, Medical Faculty, RWTH Aachen University, Pauwelsstr. 30, D-52074, Aachen, Germany.

Matthias Begemann (M)

Institute of Human Genetics, Medical Faculty, RWTH Aachen University, Pauwelsstr. 30, D-52074, Aachen, Germany.

Ingo Kurth (I)

Institute of Human Genetics, Medical Faculty, RWTH Aachen University, Pauwelsstr. 30, D-52074, Aachen, Germany.

Miriam Elbracht (M)

Institute of Human Genetics, Medical Faculty, RWTH Aachen University, Pauwelsstr. 30, D-52074, Aachen, Germany.

Thomas Eggermann (T)

Institute of Human Genetics, Medical Faculty, RWTH Aachen University, Pauwelsstr. 30, D-52074, Aachen, Germany. teggermann@ukaachen.de.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH